Multiple functional targets of the immunoregulatory activity of Galectin-1. Control of immune cell trafficking, dendritic cell physiology, and T-cell fate

In the postgenomic era, the study of the glycome-the whole repertoire of saccharides in cells and tissues-has enabled the association of unique glycan structures with specific physiological and pathological processes. The responsibility for deciphering this biological information belongs to endogeno...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Cooper, D.
Otros Autores: Ilarregui, J.M, Pesoa, S.A, Croci, D.O, Perretti, M., Rabinovich, G.A
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 2010
Materias:
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 27594caa a22023177a 4500
001 PAPER-7660
003 AR-BaUEN
005 20230518203725.0
008 190411s2010 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-77956156950 
024 7 |2 cas  |a galectin 1, 258495-34-0; Galectin 1 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a MENZA 
100 1 |a Cooper, D. 
245 1 0 |a Multiple functional targets of the immunoregulatory activity of Galectin-1. Control of immune cell trafficking, dendritic cell physiology, and T-cell fate 
260 |c 2010 
270 1 0 |m Cooper, D.; The William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom 
506 |2 openaire  |e Política editorial 
504 |a Ajuebor, M.N., Gibbs, L., Flower, R.J., Das, A.M., Perretti, M., Investigation of the functional role played by the chemokine monocyte chemoattractant protein-1 in interleukin-1-induced murine peritonitis (1998) Br. J. Pharmacol., 125, pp. 319-326 
504 |a Ajuebor, M.N., Flower, R.J., Hannon, R., Christie, M., Bowers, K., Verity, A., Perretti, M., Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model (1998) J. Leukoc. Biol., 63, pp. 108-116 
504 |a Amano, M., Galvan, M., Baum, L.G., The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death (2003) J. Biol. Chem., 278, pp. 7469-7475 
504 |a Barrionuevo, P., Beigier-Bompadre, M., Ilarregui, J.M., Toscano, M.A., Bianco, G.A., Isturiz, M.A., Rabinovich, G.A., A novel function for galectin-1 at the crossroad of innate and adaptive immunity: Galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway (2007) J. Immunol., 178, pp. 436-445 
504 |a Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T.B., Oukka, M., Weiner, H.L., Kuchroo, V.K., Reciprocal developmental pathways for the generation of pathogenic effector TH-17 and regulatory T cells (2006) Nature, 441, pp. 235-238 
504 |a Bidère, N., Su, H.C., Lenardo, M.J., Genetic disorders of programmed cell death in the immune system (2006) Annu. Rev. Immunol., 24, pp. 321-352 
504 |a Bienvenu, K., Granger, D.N., Molecular determinants of shear rate-dependent leukocyte adhesion in postcapillary venules (1993) Am. J. Physiol., 264, pp. H1504-H1508 
504 |a Blaser, C., Kaufmann, M., Müller, C., Zimmermann, C., Wells, V., Mallucci, L., Pircher, H., Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells (1998) Eur. J. Immunol., 28, pp. 2311-2319 
504 |a Blois, S.M., Ilarregui, J.M., Tometten, M., Garcia, M., Orsal, A.S., Cordo-Russo, R., Toscano, M.A., Markert, U.R., A pivotal role for galectin-1 in fetomaternal tolerance (2007) Nat. Med., 13, pp. 1450-1457 
504 |a Bluestone, J.A., Thomson, A.W., Shevach, E.M., Weiner, H.L., What does the future hold for cell-based tolerogenic therapy? (2007) Nat. Rev. Immunol., 7, pp. 650-654 
504 |a Brewer, C.F., Miceli, M.C., Baum, L.G., Clusters, bundles, arrays and lattices: Novel mechanisms for lectin-saccharide-mediated cellular interactions (2002) Curr. Opin. Struct. Biol., 12, pp. 616-623 
504 |a Cabrera, P.V., Amano, M., Mitoma, J., Chan, J., Said, J., Fukuda, M., Baum, L.G., Haploinsufficiency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell death (2006) Blood, 108, pp. 2399-2406 
504 |a Cervi, L., MacDonald, A.S., Kane, C., Dzierszinski, F., Pearce, E.J., Cutting edge: Dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses (2004) J. Immunol., 172, pp. 2016-2020 
504 |a Cooper, D., Norling, L.V., Perretti, M., Novel insights into the inhibitory effects of Galectin-1 on neutrophil recruitment under flow (2008) J. Leukoc. Biol., 83, pp. 1459-1466 
504 |a Cummings, R.D., Liu, F.T., Galectins (2008) Essentials of Glycobiology, pp. 475-487. , Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, A. Varki (Ed.) 
504 |a Dahlgren, C., Christophe, T., Boulay, F., Madianos, P.N., Rabiet, M.J., Karlsson, A., The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A(4) receptor (2000) Blood, 95, pp. 1810-1818 
504 |a Dettin, L., Rubinstein, N., Aoki, A., Rabinovich, G.A., Maldonado, C.A., Regulated expression and ultrastructural localization of galectin-1, a proapoptotic beta-galactoside-binding lectin, during spermatogenesis in rat testis (2003) Biol. Reprod., 68, pp. 51-59 
504 |a Dias-Baruffi, M., Zhu, H., Cho, M., Karmakar, S., McEver, R.P., Cummings, R.D., Dimeric galectin-1 induces surface exposure of phosphatidylserine and phagocytic recognition of leukocytes without inducing apoptosis (2003) J. Biol. Chem., 278, pp. 41282-41293 
504 |a Earl, L.A., Bi, S., Baum, L.G., N- and O-glycans modulate galectin-1 binding, CD45 signaling, and T cell death (2010) J. Biol. Chem., 285, pp. 2232-2244 
504 |a Fife, B.T., Bluestone, J.A., Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways (2008) Immunol. Rev., 224, pp. 166-182 
504 |a Fitch, F.W., Gajewski, T.F., Hu-Li, J., Production of Th1 and Th2 cell lines and clones (2008) Current Protocols in Immunology, pp. 3.13.1-3.13.15. , John Wiley & Sons, Inc, New York, J.E. Coligan (Ed.) 
504 |a Fuertes, M.B., Molinero, L.L., Toscano, M.A., Ilarregui, J.M., Rubinstein, N., Fainboim, L., Zwirner, N.W., Rabinovich, G.A., Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase (2004) Mol. Cell. Biochem., 267, pp. 177-185 
504 |a Fulcher, J.A., Chang, M.H., Wang, S., Almazan, T., Hashimi, S.T., Eriksson, A.U., Wen, X., Lee, B., Galectin-1 co-clusters CD43/CD45 on dendritic cells and induces cell activation and migration through Syk and protein kinase C signaling (2009) J. Biol. Chem., 284, pp. 26860-26870 
504 |a Galluzzi, L., Aaronson, S.A., Abrams, J., Alnemri, E.S., Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes (2009) Cell Death Differ., 16, pp. 1093-1107 
504 |a Garín, M.I., Chu, C.C., Golshayan, D., Cernuda-Morollón, E., Wait, R., Lechler, R.I., Galectin-1: A key effector of regulation mediated by CD4+CD25+ T cells (2007) Blood, 109, pp. 2058-2065 
504 |a Gil, C.D., Cooper, D., Rosignoli, G., Perretti, M., Oliani, S.M., Inflammation-induced modulation of cellular galectin-1 and -3 expression in a model of rat peritonitis (2006) Inflamm. Res., 55, pp. 99-107 
504 |a Hannier, S., Bitegye, C., Demotz, S., Early events of TCR signaling are distinct in human Th1 and Th2 cells (2002) J. Immunol., 169, pp. 1904-1911 
504 |a Harjacek, M., Diaz-Cano, S., De Miguel, M., Wolfe, H., Maldonado, C.A., Rabinovich, G.A., Expression of galectins-1 and -3 correlates with defective mononuclear cell apoptosis in patients with juvenile idiopathic arthritis (2001) J. Rheumatol., 28, pp. 1914-1922 
504 |a Hernandez, J.D., Nguyen, J.T., He, J., Wang, W., Ardman, B., Green, J.M., Fukuda, M., Baum, L.G., Galectin-1 binds different CD43 glycoforms to cluster CD43 and regulate T cell death (2006) J.Immunol, 177, pp. 5328-5336 
504 |a Hsu, K.L., Mahal, L.K., Sweet tasting chips: Microarray-based analysis of glycans (2009) Curr. Opin. Chem. Biol., 13, pp. 427-432 
504 |a Iglesias, M.M., Rabinovich, G.A., Ivanovic, V., Sotomayor, C., Wolfenstein-Todel, C., Galectin-1 from ovine placenta-amino-acid sequence, physicochemical properties and implications in T-cell death (1998) Eur. J. Biochem., 252, pp. 400-407 
504 |a Ilarregui, J.M., Rabinovich, G.A., Tolerogenic dendritic cells in the control of autoimmune neuroinflammation: An emerging role of protein-glycan interactions (2010) Neuroimmunomodulation, 17, pp. 157-160 
504 |a Ilarregui, J.M., Croci, D.O., Bianco, G.A., Toscano, M.A., Salatino, M., Vermeulen, M.E., Geffner, J.R., Rabinovich, G.A., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 (2009) Nat. Immunol., 10, pp. 981-991 
504 |a Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., Steinman, R.M., Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor (1992) J. Exp. Med., 176, pp. 1693-1702 
504 |a Ishida, K., Panjwani, N., Cao, Z., Streilein, J.W., Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms (2003) Ocul. Immunol. Inflamm., 11, pp. 91-105 
504 |a Juszczynski, P., Ouyang, J., Monti, S., Rodig, S.J., Takeyama, K., Abramson, J., Chen, W., Shipp, M.A., The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma (2007) Proc. Natl. Acad. Sci. USA, 104, pp. 13134-13139 
504 |a Kopcow, H.D., Rosetti, F., Leung, Y., Allan, D.S., Kutok, J.L., Strominger, J.L., T cell apoptosis at the maternal-fetal interface in early human pregnancy, involvement of galectin-1 (2008) Proc. Natl. Acad. Sci. USA, 105, pp. 18472-18477 
504 |a La, M., Cao, T.V., Cerchiaro, G., Chilton, K., Hirabayashi, J., Kasai, K., Oliani, S.M., Perretti, M., A novel biological activity for galectin-1: Inhibition of leukocyte-endothelial cell interactions in experimental inflammation (2003) Am. J. Pathol., 163, pp. 1505-1515 
504 |a Levi, G., Teichberg, V.I., Isolation and physicochemical characterization of electrolectin, a beta-d-galactoside binding lectin from the electric organ of Electrophorus electricus (1981) J. Biol. Chem., 256, pp. 5735-5740 
504 |a Liu, F.T., Rabinovich, G.A., Galectins as modulators of tumour progression (2005) Nat. Rev. Cancer, 5, pp. 29-41 
504 |a Lopez-Diego, R.S., Weiner, H.L., Novel therapeutic strategies for multiple sclerosis -a multifaceted adversary (2008) Nat. Rev. Drug Discov., 7, pp. 909-925 
504 |a Mangan, P.R., Harrington, L.E., O'Quinn, D.B., Helms, W.S., Bullard, D.C., Elson, C.O., Hatton, R.D., Weaver, C.T., Transforming growth factor-b induces development of the TH-17 lineage (2006) Nature, 441, pp. 231-234 
504 |a Maynard, C.L., Weaver, C.T., Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation (2008) Immunol. Rev., 226, pp. 219-233 
504 |a Morgan, R., Gao, G., Pawling, J., Dennis, J.W., Demetriou, M., Li, B., N-acetylglucosaminyltransferase V (Mgat5)-mediated N-glycosylation negatively regulates Th1 cytokine production by T cells (2004) J. Immunol., 173, pp. 7200-7208 
504 |a Motran, C.C., Molinder, K.M., Liu, S.D., Poirier, F., Miceli, M.C., Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function (2008) Eur. J. Immunol., 38, pp. 3015-3027 
504 |a Norling, L.V., Sampaio, A.L., Cooper, D., Perretti, M., Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking (2008) FASEB J., 22, pp. 682-690 
504 |a Pace, K.E., Lee, C., Stewart, P.L., Baum, L.G., Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1 (1999) J. Immunol., 163, pp. 3801-3811 
504 |a Pace, K.E., Hahn, H.P., Baum, L.G., Preparation of recombinant human galectin-1 and use in T-cell death assays (2003) Methods Enzymol., 363, pp. 499-518 
504 |a Pacienza, N., Pozner, R.G., Bianco, G.A., D'Atri, L.P., Croci, D.O., Negrotto, S., Malaver, E., Schattner, M., The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation (2008) FASEB J., 22, pp. 1113-1123 
504 |a Peggs, K.S., Quezada, S.A., Allison, J.P., Cell intrinsic mechanisms of T-cell inhibition and application to cancer therapy (2008) Immunol. Rev., 224, pp. 141-165 
504 |a Perillo, N.L., Uittenbogaart, C.H., Nguyen, J.T., Baum, L.G., Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes (1997) J. Exp. Med., 185, pp. 1851-1858 
504 |a Perone, M.J., Larregina, A.T., Shufesky, W.J., Papworth, G.D., Sullivan, M.L., Zahorchak, A.F., Stolz, D.B., Morelli, A.E., Transgenic galectin-1 induces maturation of dendritic cells that elicit contrasting responses in naive and activated T cells (2006) J. Immunol., 176, pp. 7207-7220 
504 |a Poirier, F., Robertson, E.J., Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin (1993) Development, 119, pp. 1229-1236 
504 |a Rabinovich, G.A., Galectin-1 as a potential cancer target (2005) Br. J. Cancer, 92, pp. 1188-1192 
504 |a Rabinovich, G.A., Gruppi, A., Galectins as immunoregulators during infectious processes: From microbial invasion to the resolution of the disease (2005) Parasite Immunol., 27, pp. 103-114 
504 |a Rabinovich, G.A., Ilarregui, J.M., Conveying glycan information into T-cell homeostatic programs: A challenging role for galectin-1 in inflammatory and tumor microenvironments (2009) Immunol. Rev., 230, pp. 144-159 
504 |a Rabinovich, G.A., Toscano, M.A., Turning 'sweet' on immunity: Galectin-glycan interactions in immune tolerance and inflammation (2009) Nat. Rev. Immunol., 9, pp. 338-352 
504 |a Rabinovich, G., Castagna, L., Landa, C., Riera, C.M., Sotomayor, C., Regulated expression of a 16-kd galectin-like protein in activated rat macrophages (1996) J. Leukoc. Biol., 59, pp. 363-370 
504 |a Rabinovich, G.A., Modesti, N.M., Castagna, L.F., Landa, C.A., Riera, C.M., Sotomayor, C.E., Specific inhibition of lymphocyte proliferation and induction of apoptosis by CLL-I, a beta-galactoside-binding lectin (1997) J. Biochem., 122, pp. 365-373 
504 |a Rabinovich, G.A., Iglesias, M.M., Modesti, N.M., Castagna, L.F., Wolfenstein-Todel, C., Riera, C.M., Sotomayor, C.E., Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: Biochemical and functional characterization (1998) J. Immunol., 160, pp. 4831-4840 
504 |a Rabinovich, G.A., Sotomayor, C.E., Riera, C.M., Bianco, I., Correa, S.G., Evidence of a role for galectin-1 in acute inflammation (2000) Eur. J. Immunol., 30, pp. 1331-1339 
504 |a Rabinovich, G.A., Baum, L.G., Tinari, N., Paganelli, R., Natoli, C., Liu, F.T., Iacobelli, S., Galectins and their ligands: Amplifiers, silencers or tuners of the inflammatory response? (2002) Trends. Immunol., 23, pp. 313-320 
504 |a Rabinovich, G.A., Ramhorst, R.E., Rubinstein, N., Corigliano, A., Daroqui, M.C., Kier-Joffé, E.B., Fainboim, L., Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms (2002) Cell Death Differ., 9, pp. 661-670 
504 |a Rabinovich, G.A., Liu, F.T., Hirashima, M., Anderson, A., An emerging role for galectins in tuning the immune response: Lessons from experimental models of inflammatory disease, autoimmunity and cancer (2007) Scand. J. Immunol., 66, pp. 143-158 
504 |a Rabinovich, G.A., Toscano, M.A., Jackson, S.S., Vasta, G.R., Functions of cell surface galectin-glycoprotein lattices (2007) Curr. Opin. Struct. Biol., 17, pp. 513-520 
504 |a Rabinovich, G.A., Gabrilovich, D., Sotomayor, E.M., Imunosuppressive strategies that are mediated by tumor cells (2007) Annu. Rev. Immunol., 25, pp. 267-296 
504 |a Reis e Sousa, C., Dendritic cells in a mature age (2006) Nat. Rev. Immunol., 6, pp. 476-483 
504 |a Romero, M.D., Muiño, J.C., Bianco, G.A., Ferrero, M., Juarez, C.P., Luna, J.D., Rabinovich, G.A., Circulating anti-galectin-1 antibodies are associated with the severity of ocular disease in autoimmune and infectious uveitis (2006) Invest. Ophthalmol. Vis. Sci., 47, pp. 1550-1556 
504 |a Rubinstein, N., Alvarez, M., Zwirner, N.W., Toscano, M.A., Ilarregui, J.M., Bravo, A., Mordoh, J., Rabinovich, G.A., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege (2004) Cancer Cell, 5, pp. 241-251 
504 |a Sengeløv, H., Follin, P., Kjeldsen, L., Lollike, K., Dahlgren, C., Borregaard, N., Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils (1995) J. Immunol., 154, pp. 4157-4165 
504 |a Sospedra, M., Martin, R., Immunology of multiple sclerosis (2005) Annu. Rev. Immunol., 23, pp. 683-747 
504 |a Steinman, R.M., Hawiger, D., Liu, K., Bonifaz, L., Bonnyay, D., Mahnke, K., Iyoda, T., Nussenzweig, M., Dendritic cell function in vivo during the steady state: A role in peripheral tolerance (2003) Ann. NY Acad. Sci., 987, pp. 15-25 
504 |a Stillman, B.N., Hsu, D.K., Pang, M., Brewer, C.F., Johnson, P., Liu, F.T., Baum, L.G., Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death (2006) J. Immunol., 176, pp. 778-789 
504 |a Stowell, S.R., Karmakar, S., Arthur, C.M., Ju, T., Rodrigues, L.C., Riul, T.B., Dias-Baruffi, M., Cummings, R.D., Galectin-1 induces reversible phosphatidylserine exposure at the plasma membrane (2009) Mol. Biol. Cell, 20, pp. 1408-1418 
504 |a Strasser, A., Bouillet, P., The control of apoptosis in lymphocyte selection (2003) Immunol. Rev., 193, pp. 82-92 
504 |a Sugimoto, N., Oida, T., Hirota, K., Nakamura, K., Nomura, T., Uchiyama, T., Sakaguchi, S., Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis (2006) Int. Immunol., 18, pp. 1197-1209 
504 |a Tarner, I.H., Fathman, C.G., Does our current understanding of the molecular basis of immune tolerance predict new therapies for autoimmune disease? (2006) Nat. Clin. Pract. Rheumatol., 2, pp. 491-499 
504 |a Tateno, H., Uchiyama, N., Kuno, A., Togayachi, A., Sato, T., Narimatsu, H., Hirabayashi, J., A novel strategy for mammalian cell surface glycome profiling using lectin microarray (2007) Glycobiology, 10, pp. 1138-1146 
504 |a Thijssen, V.L., Postel, R., Brandwijk, R.J., Dings, R.P., Nesmelova, I., Satijn, S., Verhofstad, N., Poirier, F., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy (2006) Proc. Natl. Acad. Sci. USA, 103, pp. 15975-15980 
504 |a Thijssen, V.L., van Beijnum, J.R., Mayo, K.H., Griffioen, A.W., Identification of novel drug targets for angiostatic cancer therapy; it takes two to tango (2007) Curr. Pharm. Des., 13, pp. 3576-3583 
504 |a Toscano, M.A., Commodaro, A.G., Ilarregui, J.M., Bianco, G.A., Liberman, A., Serra, H.M., Hirabayashi, J., Rabinovich, G.A., Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses (2006) J. Immunol., 176, pp. 6323-6332 
504 |a Toscano, M.A., Bianco, G.A., Ilarregui, J.M., Croci, D.O., Correale, J., Hernandez, J.D., Zwirner, N.W., Rabinovich, G.A., Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death (2007) Nat. Immunol., 8, pp. 825-834 
504 |a Toscano, M.A., Ilarregui, J.M., Bianco, G.A., Campagna, L., Croci, D.O., Salatino, M., Rabinovich, G.A., Dissecting the pathophysiologic role of endogenous lectins: Glycan-binding proteins with cytokine-like activity? (2007) Cytokine Growth Factor Rev., 18, pp. 57-71 
504 |a van Kooyk, Y., Rabinovich, G.A., Protein-glycan interactions in the control of innate and adaptive immune responses (2008) Nat. Immunol., 9, pp. 593-601 
504 |a Walzel, H., Blach, M., Hirabayashi, J., Kasai, K.I., Brock, J., Involvement of CD2 and CD3 in galectin-1 induced signaling in human Jurkat T-cells (2000) Glycobiology, 10, pp. 131-140 
504 |a Wang, J., Lu, Z.H., Gabius, H.J., Rohowsky-Kochan, C., Ledeen, R.W., Wu, G., Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: Possible role in suppressing experimental autoimmune encephalomyelitis (2009) J. Immunol., 182, pp. 4036-4045 
504 |a Wollina, U., Schreiber, G., Görnig, M., Feldrappe, S., Burchert, M., Gabius, H.J., Sertoli cell expression of galectin-1 and -3 and accessible binding sites in normal human testis and Sertoli cell only-syndrome (1999) Histol. Histopathol., 14, pp. 779-784 
504 |a Yang, R.Y., Rabinovich, G.A., Liu, F.T., Galectins: Structure, function and therapeutic potential (2008) Expert Rev. Mol. Med., 10, pp. e17 
504 |a Young, R.E., Thompson, R.D., Nourshargh, S., Divergent mechanisms of action of the inflammatory cytokines interleukin 1-beta and tumour necrosis factor-alpha in mouse cremasteric venules (2002) Br. J. Pharmacol., 137, pp. 1237-1246 
504 |a Zuñiga, E., Rabinovich, G.A., Iglesias, M.M., Gruppi, A., Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis (2001) J. Leukoc. Biol., 70, pp. 73-79 
504 |a Zuñiga, E., Gruppi, A., Hirabayashi, J., Kasai, K.I., ovich, G.A., Regulated expression and effect of galectin-1 on Trypanosoma cruzi-infected macrophages: Modulation of microbicidal activity and survival (2001) Infect. Immun., 69, pp. 6804-6812 
520 3 |a In the postgenomic era, the study of the glycome-the whole repertoire of saccharides in cells and tissues-has enabled the association of unique glycan structures with specific physiological and pathological processes. The responsibility for deciphering this biological information belongs to endogenous glycan-binding proteins or lectins. Galectin-1, a prototypic member of a family of structurally related proteins, has demonstrated selective antiinflammatory and immunoregulatory effects either by controlling immune cell trafficking, "fine-tuning" dendritic cell physiology and regulating T-cell fate. These regulatory functions mediated by an endogenous glycan-binding protein may contribute to fulfill the needs for immune cell homeostasis, including preservation of fetomaternal tolerance and prevention of collateral damage as a result of microbial invasion or autoimmune pathology. We will discuss here the conceptual framework which led to the study of galectin-glycan lattices as a novel paradigm of immune cell communication in physiological and pathological processes and will highlight selected methods and experimental strategies which have contributed to the study of the immunoregulatory activities of this multifaceted glycan-binding protein both in in vitro and in vivo biological settings. © 2010 Elsevier Inc.  |l eng 
536 |a Detalles de la financiación: PICT 2006-603 
536 |a Detalles de la financiación: Arthritis Research UK, 18103 
536 |a Detalles de la financiación: Work in authors' laboratories is supported by grants from The Argentinean Agency for Promotion of Science and Technology (PICT 2006-603; Argentina), Sales Foundation for Cancer Research (Argentina), The Cancer Research Institute (USA), and The Prostate Cancer Research Foundation (UK) to G. A. R., Arthritis Research UK fellowship to D. C. (18103) and the William Harvey Research Foundation to D. C. and M. P. We thank all members of our laboratories, especially M. Toscano for critical reading of the manuscript. 
593 |a The William Harvey Research Institute, Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom 
593 |a Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental, Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina 
593 |a Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina 
690 1 0 |a DENDRITIC CELLS 
690 1 0 |a GALECTIN-1 
690 1 0 |a GLYCOIMMUNOLOGY 
690 1 0 |a INFLAMMATION 
690 1 0 |a NEUTROPHILS 
690 1 0 |a T CELLS 
690 1 0 |a TOLERANCE 
690 1 0 |a TRAFFICKING 
690 1 0 |a GALECTIN 1 
690 1 0 |a ADOPTIVE TRANSFER 
690 1 0 |a ANTIINFLAMMATORY ACTIVITY 
690 1 0 |a ARTICLE 
690 1 0 |a AUTOIMMUNE DISEASE 
690 1 0 |a BINDING ASSAY 
690 1 0 |a CARBOHYDRATE ANALYSIS 
690 1 0 |a CELL COUNT 
690 1 0 |a CELL CULTURE 
690 1 0 |a CELL DEATH 
690 1 0 |a CELL DIFFERENTIATION 
690 1 0 |a CELL FATE 
690 1 0 |a CELL FUNCTION 
690 1 0 |a CELL ISOLATION 
690 1 0 |a CELL MATURATION 
690 1 0 |a CELL MIGRATION 
690 1 0 |a CELL POLARITY 
690 1 0 |a CELL SURFACE 
690 1 0 |a CELL SURVIVAL 
690 1 0 |a CHEMOTAXIS 
690 1 0 |a CONCEPTUAL FRAMEWORK 
690 1 0 |a CREMASTER MUSCLE 
690 1 0 |a DENDRITIC CELL 
690 1 0 |a DISEASE MODEL 
690 1 0 |a ENDOCYTOSIS 
690 1 0 |a ENDOTHELIUM CELL 
690 1 0 |a HELPER CELL 
690 1 0 |a HUMAN 
690 1 0 |a IMMUNOLOGICAL TOLERANCE 
690 1 0 |a IMMUNOREGULATION 
690 1 0 |a LEUKOCYTE 
690 1 0 |a MESENTERY 
690 1 0 |a MICROVASCULATURE 
690 1 0 |a MOTHER FETUS RELATIONSHIP 
690 1 0 |a NONHUMAN 
690 1 0 |a PERITONITIS 
690 1 0 |a PHENOTYPE 
690 1 0 |a PRIORITY JOURNAL 
690 1 0 |a PROTEIN FUNCTION 
690 1 0 |a QUANTITATIVE ANALYSIS 
690 1 0 |a REAL TIME POLYMERASE CHAIN REACTION 
690 1 0 |a REGULATORY MECHANISM 
690 1 0 |a T LYMPHOCYTE 
690 1 0 |a TH1 CELL 
690 1 0 |a TH17 CELL 
690 1 0 |a TH2 CELL 
690 1 0 |a WESTERN BLOTTING 
690 1 0 |a ANIMALS 
690 1 0 |a CHEMOTAXIS, LEUKOCYTE 
690 1 0 |a DENDRITIC CELLS 
690 1 0 |a GALECTIN 1 
690 1 0 |a HUMANS 
690 1 0 |a IMMUNE SYSTEM 
690 1 0 |a IMMUNOMODULATION 
690 1 0 |a LABORATORY TECHNIQUES AND PROCEDURES 
690 1 0 |a MODELS, BIOLOGICAL 
690 1 0 |a T-LYMPHOCYTES 
650 1 7 |2 spines  |a HOMEOSTASIS 
650 1 7 |2 spines  |a HOMEOSTASIS 
700 1 |a Ilarregui, J.M. 
700 1 |a Pesoa, S.A. 
700 1 |a Croci, D.O. 
700 1 |a Perretti, M. 
700 1 |a Rabinovich, G.A. 
773 0 |d 2010  |g v. 480  |h pp. 199-244  |k n. C  |p Methods Enzymol.  |x 00766879  |w (AR-BaUEN)CENRE-793  |t Methods in Enzymology 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-77956156950&doi=10.1016%2fS0076-6879%2810%2980011-4&partnerID=40&md5=98fee6840b8834e88ca8ac200fccafd1  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/S0076-6879(10)80011-4  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_00766879_v480_nC_p199_Cooper  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00766879_v480_nC_p199_Cooper  |y Registro en la Biblioteca Digital 
961 |a paper_00766879_v480_nC_p199_Cooper  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion 
999 |c 68613